Coastline Trust Co decreased its holdings in shares of Colgate-Palmolive (NYSE:CL) by 6.2% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 54,300 shares of the company’s stock after selling 3,570 shares during the quarter. Coastline Trust Co’s holdings in Colgate-Palmolive were worth $3,955,000 at the end of the most recent reporting period.
A number of other institutional investors have also made changes to their positions in the business. Northstar Group Inc. lifted its holdings in shares of Colgate-Palmolive by 5.6% during the second quarter. Northstar Group Inc. now owns 5,120 shares of the company’s stock worth $380,000 after buying an additional 270 shares in the last quarter. Trust Co. of Toledo NA OH lifted its holdings in shares of Colgate-Palmolive by 8.2% during the second quarter. Trust Co. of Toledo NA OH now owns 5,487 shares of the company’s stock worth $407,000 after buying an additional 417 shares in the last quarter. Peak Capital Management LLC acquired a new stake in shares of Colgate-Palmolive during the second quarter worth $204,000. Fisher Asset Management LLC lifted its holdings in shares of Colgate-Palmolive by 793.3% during the second quarter. Fisher Asset Management LLC now owns 236,799 shares of the company’s stock worth $17,554,000 after buying an additional 210,290 shares in the last quarter. Finally, National Pension Service lifted its holdings in shares of Colgate-Palmolive by 8.8% during the second quarter. National Pension Service now owns 652,934 shares of the company’s stock worth $48,395,000 after buying an additional 53,000 shares in the last quarter. 72.85% of the stock is owned by institutional investors and hedge funds.
In other Colgate-Palmolive news, Director Stephen I. Sadove sold 20,780 shares of Colgate-Palmolive stock in a transaction dated Monday, November 6th. The stock was sold at an average price of $70.52, for a total value of $1,465,405.60. Following the transaction, the director now owns 36,268 shares in the company, valued at $2,557,619.36. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, insider Jennifer Daniels sold 902 shares of Colgate-Palmolive stock in a transaction dated Tuesday, January 9th. The shares were sold at an average price of $75.82, for a total value of $68,389.64. Following the completion of the transaction, the insider now owns 37,788 shares in the company, valued at approximately $2,865,086.16. The disclosure for this sale can be found here. Insiders sold 181,950 shares of company stock worth $13,237,385 in the last 90 days. 1.02% of the stock is owned by company insiders.
Colgate-Palmolive (NYSE CL) opened at $77.50 on Monday. The company has a debt-to-equity ratio of 24.42, a current ratio of 1.23 and a quick ratio of 0.92. Colgate-Palmolive has a 12-month low of $63.43 and a 12-month high of $77.91. The company has a market capitalization of $68,053.16, a price-to-earnings ratio of 27.00, a P/E/G ratio of 3.24 and a beta of 0.80.
Colgate-Palmolive (NYSE:CL) last issued its quarterly earnings results on Friday, October 27th. The company reported $0.73 EPS for the quarter, hitting the Zacks’ consensus estimate of $0.73. Colgate-Palmolive had a return on equity of 2,782.56% and a net margin of 15.10%. The company had revenue of $3.97 billion for the quarter, compared to analysts’ expectations of $3.94 billion. During the same quarter last year, the business earned $0.73 earnings per share. Colgate-Palmolive’s revenue was up 2.8% on a year-over-year basis. analysts expect that Colgate-Palmolive will post 2.87 EPS for the current fiscal year.
The business also recently declared a quarterly dividend, which will be paid on Thursday, February 15th. Investors of record on Tuesday, January 23rd will be given a $0.40 dividend. This represents a $1.60 dividend on an annualized basis and a dividend yield of 2.06%. The ex-dividend date of this dividend is Monday, January 22nd. Colgate-Palmolive’s payout ratio is currently 61.78%.
A number of equities research analysts have recently weighed in on CL shares. Zacks Investment Research raised Colgate-Palmolive from a “hold” rating to a “buy” rating and set a $80.00 target price for the company in a report on Monday, September 25th. SunTrust Banks raised Colgate-Palmolive from a “hold” rating to a “buy” rating and lifted their target price for the stock from $65.00 to $85.00 in a report on Wednesday, October 11th. Jefferies Group dropped their target price on Colgate-Palmolive from $79.00 to $76.00 and set a “hold” rating for the company in a report on Monday, October 30th. Stifel Nicolaus set a $73.00 target price on Colgate-Palmolive and gave the stock a “hold” rating in a report on Sunday, October 29th. Finally, KeyCorp reissued a “hold” rating on shares of Colgate-Palmolive in a report on Monday, October 16th. Two analysts have rated the stock with a sell rating, thirteen have assigned a hold rating and six have issued a buy rating to the stock. Colgate-Palmolive currently has an average rating of “Hold” and an average target price of $76.45.
COPYRIGHT VIOLATION WARNING: This news story was reported by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are reading this news story on another website, it was illegally stolen and republished in violation of U.S. and international copyright and trademark law. The correct version of this news story can be accessed at https://www.dispatchtribunal.com/2018/01/22/coastline-trust-co-cuts-holdings-in-colgate-palmolive-cl.html.
Colgate-Palmolive Company Profile
Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.